Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Hypogonadism 4Eunuchism 2Testicular Neoplasms 1Prostatic Neoplasms 1Prostate Cancer Recurrent 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Klinefelter Syndrome 1Infertility 1Fatigue Syndrome, Chronic 1Carcinoma, Renal Cell 1

Interventions

Fulvestrant 5Exercise 5Eating 5Standard of Care 3Sodium Chloride 3Diet 3Alpelisib 3ribociclib 2gallium Ga 68 dotatate 2exemestane 2Vitamin D 2Tamoxifen 2Magnetic Resonance Spectroscopy 2Letrozole 2Ethanol 2Blood Specimen Collection 2Anastrozole 2zopiclone 1ziprasidone 1veliparib 1testosterone undecanoate 1testosterone enanthate 1pazopanib 1mirabegron 1methyl hydroxyethyl cellulose 1lenvatinib 1fluorocholine 1evolocumab 1dimethandrolone-undecanoate 1cyclopropapyrroloindole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Endocrine Neoplasia Type 1 × testosterone undecanoate × Clear all
NCT00119483 2011-09-05

Older Men and Testosterone

University Hospital of North Norway

Phase NA Completed
200 enrolled
Endocrine

Hypogonadism, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡